Axiron Topical Solution 30Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

AXIRON: Topical solution (30mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
AXIRON Topical Solution

What is this Medicine?

TESTOSTERONE (tes TOS ter one) is the main male hormone. It supports normal male traits such as muscle growth, facial hair, and deep voice. This medicine is used in males to treat low testosterone levels.

CVS Pharmacy Patient Statistics for AXIRON: Topical solution(30mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

AXIRON 30mg/actuation Topical Solution

NDC: 000021975
  • Prescription Required
  • Federally Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hypogonadism

Sometimes used for but not FDA approved for the following conditions:
Erectile Dysfunction (ED)

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
AXIRON 30mg/actuation Topical Solution

Reported Side Effects for AXIRON 30mg/actuation Topical Solution

Vomiting Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Causing To Be Hungry Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
<7.0%*
Severity: MODERATE
Onset: EARLY
Hostility Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Secretion Of Tears Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Skin Irritation Incidence:
<8.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Pelvic Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Feeling Sick Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Hair Follicles Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Breast Pain Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Increased Blood Sugar Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Acne Incidence:
1.0-8.0%*
Severity: MILD
Onset: DELAYED
Enlarged Prostate Incidence:
1.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Nervousness Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
1.0%*
Severity: MILD
Onset: RAPID
Gynecomastia Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Emotional Lability Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
1.0-6.0%*
Severity: MILD
Onset: EARLY
Hot Flashes Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
High Blood Pressure Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Decreased Sexual Desire Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Intestinal Bleeding Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More